The Union health ministry has decided to incorporate changes in the CoWIN app to allow addition of Bharat Biotech's nasal COVID-19 vaccine, paving way for its inclusion as a heterologous booster dose in the country's immunisation drive against coronavirus.
The option of this vaccine is set to reflect on CoWin to all users from the December 23 evening. This vaccine will now be offered to the adults earlier fully vaccinated with Covaxin or Covishield or to those who may not have taken any coronavirus vaccine so far.
It will, however, will only be available at private hospitals and the rate is yet to be determined. Government sources said that as of now there is no plan to procure the vaccine for the public run hospitals where booster or precautionary doses are offered free of cost to all those aged 60 years and above.